Publication | Closed Access

An overview of the initial experience with AK-2123 as a hypoxic cell sensitizer with radiation in the treatment of advanced head and neck cancers

Advanced HeadRadiation TherapyMedicineImmunologyInitial ExperienceRadiopharmaceutical TherapyHead And Neck CancerNeck OncologyOncologyRadiation OncologyTreatment ResistanceHypoxic Cell Sensitizer